STOCK TITAN

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Ironwood Pharmaceuticals (Nasdaq: IRWD) has announced its participation in the 2024 Wells Fargo Healthcare Conference. The company will engage in a fireside chat on Thursday, September 5, 2024, at 2:15 p.m. ET at the Encore Boston Harbor.

Investors and interested parties can access a live webcast of the fireside chat through the Investors section of Ironwood's official website at www.ironwoodpharma.com. For those unable to attend or watch live, a replay of the webcast will be available on the company's website for one year following the conference.

This participation provides an opportunity for Ironwood Pharmaceuticals to engage with investors and share insights about their business and future prospects in the healthcare sector.

Ironwood Pharmaceuticals (Nasdaq: IRWD) ha annunciato la sua partecipazione alla Conferenza Sanitaria Wells Fargo 2024. L'azienda parteciperà a un fireside chat che si terrà giovedì 5 settembre 2024, alle 14:15 ET presso l'Encore Boston Harbor.

Gli investitori e le parti interessate possono accedere a un webcast dal vivo del fireside chat attraverso la sezione Investitori del sito ufficiale di Ironwood all'indirizzo www.ironwoodpharma.com. Per coloro che non possono partecipare o guardare dal vivo, un ripasso del webcast sarà disponibile sul sito dell'azienda per un anno dopo la conferenza.

Questa partecipazione offre a Ironwood Pharmaceuticals l'opportunità di interagire con gli investitori e condividere approfondimenti sulla loro attività e le prospettive future nel settore sanitario.

Ironwood Pharmaceuticals (Nasdaq: IRWD) ha anunciado su participación en la Conferencia de Salud Wells Fargo 2024. La empresa participará en un fireside chat el jueves 5 de septiembre de 2024, a las 2:15 p.m. ET en el Encore Boston Harbor.

Los inversores y partes interesadas pueden acceder a un webcast en vivo del fireside chat a través de la sección de Inversores del sitio web oficial de Ironwood en www.ironwoodpharma.com. Para aquellos que no puedan asistir o ver en vivo, habrá una repetición del webcast disponible en el sitio de la empresa por un año después de la conferencia.

Esta participación brinda a Ironwood Pharmaceuticals la oportunidad de interactuar con inversores y compartir ideas sobre su negocio y perspectivas futuras en el sector de la salud.

아이언우드 제약회사 (Nasdaq: IRWD)는 2024 웰스파고 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 회사는 2024년 9월 5일 목요일, 오후 2시 15분 ET엔코어 보스턴 하버에서 파이어사이드 챗을 진행할 예정입니다.

투자자 및 관심 있는 분들은 www.ironwoodpharma.com의 아이언우드 공식 웹사이트 투자자 섹션을 통해 파이어사이드 챗의 라이브 웹캐스트에 접근할 수 있습니다. 참석하거나 생중계를 시청할 수 없는 분들을 위해, 컨퍼런스 후 1년 동안 회사 웹사이트에서 웹캐스트 재상영이 제공될 예정입니다.

이번 참여는 아이언우드 제약회사가 투자자와 소통하고 헬스케어 분야에서의 사업 및 향후 전망에 대한 통찰을 공유할 수 있는 기회를 제공합니다.

Ironwood Pharmaceuticals (Nasdaq: IRWD) a annoncé sa participation à la Conférence sur la santé Wells Fargo 2024. L'entreprise participera à un fireside chat le jeudi 5 septembre 2024, à 14 h 15 ET à l'Encore Boston Harbor.

Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct du fireside chat via la section Investisseurs du site officiel d'Ironwood à l'adresse www.ironwoodpharma.com. Pour ceux qui ne peuvent pas assister ou regarder en direct, une rediffusion du webinaire sera disponible sur le site de l'entreprise pendant un an après la conférence.

Cette participation offre à Ironwood Pharmaceuticals l'opportunité d'interagir avec les investisseurs et de partager des informations sur ses activités et ses perspectives futures dans le secteur de la santé.

Ironwood Pharmaceuticals (Nasdaq: IRWD) hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 bekannt gegeben. Das Unternehmen wird am Donnerstag, den 5. September 2024, um 14:15 Uhr ET an einem Fireside Chat im Encore Boston Harbor teilnehmen.

Investoren und interessierte Parteien können auf einen Live-Webcast des Fireside Chats über den Bereich für Investoren auf der offiziellen Website von Ironwood unter www.ironwoodpharma.com zugreifen. Für diejenigen, die nicht teilnehmen oder live zuschauen können, wird eine Wiederholung des Webcasts ein Jahr lang nach der Konferenz auf der Website des Unternehmens verfügbar sein.

Die Teilnahme bietet Ironwood Pharmaceuticals die Möglichkeit, mit Investoren in Kontakt zu treten und Einblicke in ihr Geschäft und die zukünftigen Perspektiven im Gesundheitssektor zu teilen.

Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024 at 2:15 p.m. ET at the Encore Boston Harbor.

A live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. A replay of the webcast will be available on Ironwood’s website for 1 year following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland.

We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on X and on LinkedIn.

Investors:

Greg Martini, 617-374-5230

gmartini@ironwoodpharma.com

Matt Roache, 617-621-8395

mroache@ironwoodpharma.com

Media:

Beth Calitri, 978-417-2031

bcalitri@ironwoodpharma.com

Source: Ironwood Pharmaceuticals, Inc.

FAQ

When and where is Ironwood Pharmaceuticals (IRWD) participating in the 2024 Wells Fargo Healthcare Conference?

Ironwood Pharmaceuticals (IRWD) is participating in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024, at 2:15 p.m. ET at the Encore Boston Harbor.

How can investors access Ironwood Pharmaceuticals' (IRWD) fireside chat at the Wells Fargo Healthcare Conference?

Investors can access a live webcast of Ironwood Pharmaceuticals' (IRWD) fireside chat through the Investors section of the company's website at www.ironwoodpharma.com.

How long will the replay of Ironwood Pharmaceuticals' (IRWD) fireside chat be available on their website?

The replay of Ironwood Pharmaceuticals' (IRWD) fireside chat will be available on their website for 1 year following the conference.

What is the stock symbol for Ironwood Pharmaceuticals mentioned in the press release?

The stock symbol for Ironwood Pharmaceuticals mentioned in the press release is IRWD, and it is listed on the Nasdaq stock exchange.

Ironwood Pharmaceuticals, Inc. -

NASDAQ:IRWD

IRWD Rankings

IRWD Latest News

IRWD Stock Data

694.86M
159.74M
1.69%
109.68%
9.89%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BOSTON